Researchers invent a quick-release medical tape that minimizes neonatal skin injury

No more tears from tears

 

Boston, MA, USA (October 29, 2012) Commercial medical tapes on the market today are great at keeping medical devices attached to the skin, but often can do damage—such as skin tissue tearing—once it’s time to remove them. A research team from Brigham and Women’s Hospital (BWH) has invented a quick-release tape that has the strong adhesion properties of commercial medical tape, but without the ouch factor upon removal.

The team was led by Jeffrey Karp, PhD, BWH Division of Biomedical Engineering, Department of Medicine, senior study author in collaboration with The Institute for Pediatric Innovation which defined the need and requirements for a new neonatal adhesive based on national surveys of neonatal clinicians.

 

The study detailing the tape design will be electronically published on October 29, 2012 in the Proceedings of the National Academy of Sciences. The research was conducted in collaboration with Robert Langer, PhD at the Massachusetts Institute of Technology.

 

The tape which achieves strong adhesion when securing medical devices to skin, but could also easily peel off safely, utilizes a three-layer design approach that sets a new paradigm for quick-release medical tapes.

 

"Current adhesive tapes that contain backing and adhesive layers are tailored to fracture at the adhesive-skin interface. With adults the adhesive fails leaving small remnants of adhesive on the skin while with fragile neonate skin, the fracture is more likely to occur in the skin causing significant damage," said Karp. "Our approach transitions the fracture zone away from the skin to the adhesive-backing interface thus completely preventing any harm during removal."

 

The approach incorporates an anisotropic adhesive interface between the backing and adhesive layers. The anisotropic properties of this middle layer means that it has different physical properties dependent on direction. For instance, take wood, which is stronger along the grain than across it.

 

The researchers employed laser etching and a release liner to create the anisotropic interface resulting in a medical tape with high shear strength (for strong adhesion) and low peel force (for safe, quick removal). Once the backing is peeled off, any remaining adhesive left on the skin can safely be rolled off with a finger using a "push and roll" technique.

 

"This is one of the biggest problems faced in the neonate units, where the patients are helpless and repeatedly wrapped in medical tapes designed for adult skin," said Bryan Laulicht, PhD, BWH Division of Biomedical Engineering, Department of Medicine, lead study author.

 

There are more than 1.5 million injuries each year in the United States caused by medical tape removal. Such injuries in babies and the elderly—populations with fragile skin—can range from skin irritation to permanent scarring.

 

 

This research was supported by the Institute for Pediatric Innovation via Philips Children’s Medical Ventures and the National Institutes of Health (DE013023 and GM086433). The study was also done in part with consultation from The Children’s Mercy Hospital, Kansas City, Missouri.

 

Brigham and Women’s Hospital (BWH) is a 793-bed nonprofit teaching affiliate of Harvard Medical School and a founding member of Partners HealthCare. BWH has more than 3.5 million annual patient visits, is the largest birthing center in New England and employs nearly 15,000 people. The Brigham’s medical preeminence dates back to 1832, and today that rich history in clinical care is coupled with its national leadership in patient care, quality improvement and patient safety initiatives, and its dedication to research, innovation, community engagement and educating and training the next generation of health care professionals. Through investigation and discovery conducted at its Biomedical Research Institute (BRI), BWH is an international leader in basic, clinical and translational research on human diseases, involving nearly 1,000 physician-investigators and renowned biomedical scientists and faculty supported by nearly $625 million in funding. BWH continually pushes the boundaries of medicine, including building on its legacy in organ transplantation by performing the first face transplants in the U.S. in 2011. BWH is also home to major landmark epidemiologic population studies, including the Nurses‘ and Physicians‘ Health Studies, OurGenes and the Women’s Health Initiative. For more information and resources, please visit BWH’s online newsroom

 


 

Brigham and Women’s Hospital, National Institutes of Health, 29.10.2012 (tB).

MEDICAL NEWS

IU School of Medicine researchers develop blood test for anxiety
COVID-19 pandemic increased rates and severity of depression, whether people…
COVID-19: Bacterial co-infection is a major risk factor for death,…
Regenstrief-led study shows enhanced spiritual care improves well-being of ICU…
Hidden bacteria presents a substantial risk of antimicrobial resistance in…

SCHMERZ PAINCARE

Hydromorphon Aristo® long ist das führende Präferenzpräparat bei Tumorschmerz
Sorgen und Versorgen – Schmerzmedizin konkret: „Sorge als identitätsstiftendes Element…
Problem Schmerzmittelkonsum
Post-Covid und Muskelschmerz
Kopfschmerz bei Übergebrauch von Schmerz- oder Migränemitteln

DIABETES

Wie das Dexom G7 abstrakte Zahlen mit Farben greifbar macht…
Diabetes mellitus: eine der großen Volkskrankheiten im Blickpunkt der Schmerzmedizin
Suliqua®: Einfacher hin zu einer guten glykämischen Kontrolle
Menschen mit Diabetes während der Corona-Pandemie unterversorgt? Studie zeigt auffällige…
Suliqua® zur Therapieoptimierung bei unzureichender BOT

ERNÄHRUNG

Positiver Effekt der grünen Mittelmeerdiät auf die Aorta
Natriumaufnahme und Herz-Kreislaufrisiko
Tierwohl-Fleisch aus Deutschland nur mäßig attraktiv in anderen Ländern
Diät: Gehirn verstärkt Signal an Hungersynapsen
Süßigkeiten verändern unser Gehirn

ONKOLOGIE

Strahlentherapie ist oft ebenso effizient wie die OP: Neues vom…
Zanubrutinib bei chronischer lymphatischer Leukämie: Zusatznutzen für bestimmte Betroffene
Eileiter-Entfernung als Vorbeugung gegen Eierstockkrebs akzeptiert
Antibiotika als Störfaktor bei CAR-T-Zell-Therapie
Bauchspeicheldrüsenkrebs: Spezielle Diät kann Erfolg der Chemotherapie beeinflussen

MULTIPLE SKLEROSE

Multiple Sklerose: Aktuelle Immunmodulatoren im Vergleich
Neuer Biomarker für Verlauf von Multipler Sklerose
Multiple Sklerose: Analysen aus Münster erhärten Verdacht gegen das Epstein-Barr-Virus
Aktuelle Daten zu Novartis Ofatumumab und Siponimod bestätigen Vorteil des…
Multiple Sklerose durch das Epstein-Barr-Virus – kommt die MS-Impfung?

PARKINSON

Meilenstein in der Parkinson-Forschung: Neuer Alpha-Synuclein-Test entdeckt die Nervenerkrankung vor…
Neue Erkenntnisse für die Parkinson-Therapie
Cochrane Review: Bewegung hilft, die Schwere von Bewegungssymptomen bei Parkinson…
Technische Innovationen für eine maßgeschneiderte Parkinson-Diagnostik und Therapie
Biomarker und Gene: neue Chancen und Herausforderungen für die Parkinson-Diagnose…